IARS1 and Alzheimer disease: In neural-derived blood exosomes obtained from preclinical subjects (individuals with asymptomatic amyloidosis who are cognitively intact 1–10 years before their AD diagnosis) or AD patients, the total level of IRS-1 is decreased to a lesser extent compared to the level of IRS-1pTyr.